Evidence map›Paper›PMID 35136019›Full record

ArticleCell death discovery2022

Role of mTORC1 activity during early retinal development and lamination in human-induced pluripotent stem cell-derived retinal organoids.

Si Hyung Lee, Jung Woo Han, Jin Young Yang, Hyoung Oh Jun, Ji Hong Bang, Heejeong Shin, Ji Hye Choi, Jongwoo Lee, Sanjar Batirovich Madrakhimov, Kyung Hwun Chung and 3 more

Open access · goldAbstract read
In one paragraph

Article in Cell death discovery, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 3 countries.

Si Hyung Lee *Department of Ophthalmology, College of Medicine, Soonchunhyang University, Cheonan, Republic of Korea.
Jung Woo Han *Department of Ophthalmology, Soonchunhyang University Hospital Bucheon, Bucheon, Republic of Korea.
Jin Young YangLaboratory of Molecular Therapy for Retinal Degeneration, Hyangseol Medical Research Institute, Soonchunhyang University Hospital Bucheon, Bucheon, Republic of Korea.
Hyoung Oh JunLaboratory of Molecular Therapy for Retinal Degeneration, Hyangseol Medical Research Institute, Soonchunhyang University Hospital Bucheon, Bucheon, Republic of Korea.
Ji Hong BangLaboratory of Molecular Therapy for Retinal Degeneration, Hyangseol Medical Research Institute, Soonchunhyang University Hospital Bucheon, Bucheon, Republic of Korea.
Heejeong ShinLaboratory of Molecular Therapy for Retinal Degeneration, Hyangseol Medical Research Institute, Soonchunhyang University Hospital Bucheon, Bucheon, Republic of Korea.
Ji Hye ChoiLaboratory of Molecular Therapy for Retinal Degeneration, Hyangseol Medical Research Institute, Soonchunhyang University Hospital Bucheon, Bucheon, Republic of Korea.
Jongwoo LeeDepartment of Biological Sciences, Sungkyunkwan University, Suwon, Republic of Korea.
Sanjar Batirovich MadrakhimovAkfa University Medical School, Tashkent, Uzbekistan.
Kyung Hwun ChungLaboratory of Molecular Therapy for Retinal Degeneration, Hyangseol Medical Research Institute, Soonchunhyang University Hospital Bucheon, Bucheon, Republic of Korea.
Hun Soo ChangDepartment of Anatomy and BK21 Four Project, College of Medicine, Soonchunhyang University, Cheonan, Republic of Korea.
Jungmook LyuDepartment of Medical Science, Konyang University, Daejun, Republic of Korea.
Tae Kwann ParkDepartment of Ophthalmology, College of Medicine, Soonchunhyang University, Cheonan, Republic of Korea. tkpark@schmc.ac.kr.ORCID http://orcid.org/0000-0001-9689-4384
Soonchunhyang University · KRSoonchunhyang University Hospital Seoul · KRCentral Asian University · UZKonyang University · KRSungkyunkwan University · KR

Funding

Ministry of Education (Ministry of Education of the Republic of Korea) 2019R1A2C1005055Ministry of Education (Ministry of Education of the Republic of Korea) 2020R1I1A3053309Ministry of Health and Welfare (Ministry of Health, Welfare and Family Affairs) HI21C0317Ministry of Trade, Industry and Energy (Ministry of Trade, Industry and Energy, Korea) 20009844
6 · The paper itself

Abstract

Retinal organoids derived from human-induced pluripotent stem cells (hiPSC) are powerful tools for studying retinal development as they model spatial and temporal differentiation of retinal cell types. Vertebrate retinal development involves a delicate and coordinated process of retinal progenitor cell (RPC) differentiation, and the mammalian target of rapamycin complex 1 (mTORC1) has been reported to play a significant role in this complex process. Herein, using hiPSC-derived retinal organoids, we identify the time-dependent role of mTORC1 in retinal development, specifically in retinal ganglion cell (RGC) differentiation and the retinal lamination process, during the early stages of retinal organoid (RO) development. mTORC1 activity in ROs was the highest at 40 days of differentiation. MHY1485-induced hyperactivation of mTORC1 during this period resulted in a significant increase in the overall size of ROs compared to the untreated controls and rapamycin-treated Ros; there was also a marked increase in proliferative activity within the inner and outer layers of ROs. Moreover, the MHY1485-treated ROs showed a significant increase in the number of ectopic RGCs in the outer layers (indicating disruption of retinal laminar structure), with robust expression of HuC/D-binding proteins in the inner layers. These results demonstrate that mTORC1 plays a critical role in the development of hiPSC-derived ROs, especially during the early stages of differentiation.

Identifiers

PMID35136019
PMCPMC8826382
OpenAlexW4210924051

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.